We are live on
!
Find out more
EA
Emerald Acquisition Portfolio holdings
AUM
$51.8B
This Fund
S&P 500
This Quarter
Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow
% of AUM
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.06% |
| 2 | Healthcare | 12.4% |
| 3 | Technology | 11.83% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Westwood Holdings Group
WHG
$182M
| $880K | ﹤0.01% |
16,563
-15,093
| -48% | -$790K |
|
2152
ArcBest
ARCB
$3.55B
| $879K | ﹤0.01% |
46,205
-2,200
| -5% | -$39.8K |
|
2153
GSK
GSK
$102B
| $878K | ﹤0.01% |
16,278
-57,413
| -78% | -$3.15M |
|
2154
John Wiley & Sons Class A
WLY
$2.51B
| $878K | ﹤0.01% |
17,004
-13,226
| -44% | -$724K |
|
|
SKIS
2155
DELISTED
Peak Resorts, Inc.
SKIS
| $874K | ﹤0.01% |
171,713
-16,000
| -9% | -$77.4K |
|
|
COVS
2156
DELISTED
Covisint Corporation
COVS
| $874K | ﹤0.01% |
401,100
-18,811
| -4% | -$41.1K |
|
2157
Great Elm Group
GEG
$68M
| $873K | ﹤0.01% |
186,208
| – | – |
|
|
SCLN
2158
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $873K | ﹤0.01% |
85,139
+25,527
| +43% | +$278K |
|
2159
Marcus & Millichap
MMI
$1.14B
| $871K | ﹤0.01% |
33,280
-5,891
| -15% | -$156K |
|
2160
GATX Corp
GATX
$6.4B
| $869K | ﹤0.01% |
19,511
-21,650
| -53% | -$954K |
|
|
CYBE
2161
DELISTED
Cyberoptics Corp
CYBE
| $868K | ﹤0.01% |
+35,300
| New | +$679K |
|
2162
Star Group
SGU
$424M
| $866K | ﹤0.01% |
89,684
| – | – |
|
2163
AeroVironment
AVAV
$7.61B
| $865K | ﹤0.01% |
35,433
+3,800
| +12% | +$102K |
|
2164
Berkshire Hathaway Class A
BRK.A
$1.05T
| $865K | ﹤0.01% |
4
-1
| -20% | -$219K |
|
|
DGI
2165
DELISTED
DigitalGlobe Inc.
DGI
| $863K | ﹤0.01% |
31,371
+18,676
| +147% | +$479K |
|
|
AAT
2166
American Assets Trust
AAT
$1.49B
| $857K | ﹤0.01% |
19,760
+18,946
| +2,328% | +$839K |
|
2167
AutoNation
AN
$6.89B
| $857K | ﹤0.01% |
17,608
+3,580
| +26% | +$176K |
|
|
CUDA
2168
DELISTED
Barracuda Networks, Inc.
CUDA
| $855K | ﹤0.01% |
+33,557
| New | +$737K |
|
2169
Perdoceo Education
PRDO
$1.84B
| $847K | ﹤0.01% |
124,713
+94,713
| +316% | +$644K |
|
2170
Chegg
CHGG
$99.9M
| $842K | ﹤0.01% |
+118,712
| New | +$760K |
|
2171
BOK Financial
BOKF
$8.6B
| $840K | ﹤0.01% |
12,182
+95
| +0.8% | +$6.3K |
|
|
LOXO
2172
DELISTED
Loxo Oncology, Inc
LOXO
| $839K | ﹤0.01% |
32,042
-7,570
| -19% | -$198K |
|
2173
Donaldson
DCI
$10.5B
| $838K | ﹤0.01% |
22,450
-9,793
| -30% | -$357K |
|
|
PTHN
2174
DELISTED
Patheon N.V.
PTHN
| $838K | ﹤0.01% |
+28,256
| New | +$774K |
|
|
SF
2175
Stifel
SF
$12B
| $837K | ﹤0.01% |
48,958
-92,243
| -65% | -$1.48M |
|
Similar funds
SAMC
AI
JHC
EDRAMF
PRA
TH
GF
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.